Pages that link to "Q34289520"

The following pages link to Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers (Q34289520):

Displaying 34 items.

• Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? (Q28085485) (← links)
• Familial cancer among consecutive uterine cancer patients in Sweden (Q33646157) (← links)
• Genetic predisposition to colorectal cancer: where we stand and future perspectives (Q34008801) (← links)
• Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas (Q34393793) (← links)
• Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. (Q35063442) (← links)
• Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer (Q35181103) (← links)
• Comparative effectiveness of screening strategies for Lynch syndrome. (Q35474031) (← links)
• Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening (Q36041678) (← links)
• The importance to update the guidelines for the use of genetic testing in noncancer patients in Brazil. (Q36121036) (← links)
• Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer (Q36385676) (← links)
• CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein. (Q36835342) (← links)
• The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry (Q37733942) (← links)
• A massive parallel sequencing workflow for diagnostic genetic testing of mismatch repair genes (Q38364721) (← links)
• A simplified method for segregation analysis (SISA) to determine penetrance and expression of a genetic variant in a family (Q38494827) (← links)
• Mismatch repair deficiency testing in clinical practice (Q38741029) (← links)
• Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations (Q39218994) (← links)
• Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database (Q40221041) (← links)
• The analysis of a large Danish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 11q24. (Q41337851) (← links)
• Current Lynch syndrome tumor screening practices: a survey of genetic counselors. (Q45898127) (← links)
• In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. (Q48002783) (← links)
• Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds (Q48162236) (← links)
• Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome. (Q48240037) (← links)
• Teenage colorectal polyposis and cancer may be caused by constitutional mismatch repair deficiency (CMMRD). (Q48483117) (← links)
• Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score (Q49514109) (← links)
• Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome. (Q52633302) (← links)
• A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants. (Q54338096) (← links)
• Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries. (Q54983718) (← links)
• Hereditary colorectal cancer diagnostics in southern Sweden: retrospective evaluation and future considerations with emphasis on Lynch syndrome (Q57151653) (← links)
• From colorectal cancer pattern to the characterization of individuals at risk: picture for genetic research in Latin America (Q57284119) (← links)
• Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation (Q58562100) (← links)
• The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome (Q63966105) (← links)
• Uterine endometrial carcinoma with DNA mismatch repair deficiency: magnetic resonance imaging findings and clinical features (Q88575143) (← links)
• The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care (Q90447385) (← links)
• Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (Q92134834) (← links)